
  
    
      
        Background_NNP
        The_DT DNA_NNP damage_NN checkpoint_NN of_IN eukaryotic_JJ cells_NNS helps_VBZ
        ensure_VB that_IN DNA_NNP damage_NN is_VBZ repaired_VBN before_IN it_PRP causes_VBZ
        permanent_JJ ,_, genetic_JJ alterations_NNS [_NN 1_CD 2_CD 3_CD ]_NN ._. To_TO accomplish_VB
        this_DT ,_, the_DT checkpoint_NN monitors_VBZ the_DT genome_NN for_IN damaged_VBN DNA_NNP ._.
        Once_RB damage_NN is_VBZ sensed_VBD ,_, the_DT checkpoint_NN delays_VBZ the_DT cell_NN cycle_NN
        to_TO allow_VB DNA_NNP repair_NN enzymes_NNS sufficient_JJ time_NN to_TO execute_VB
        their_PRP$ activities_NNS ._. Evidence_NN also_RB shows_VBZ that_IN checkpoint_NN
        proteins_NNS interface_NN with_IN DNA_NNP repair_NN enzymes_NNS [_NN 4_CD ]_NN ._. The_DT
        importance_NN of_IN this_DT genomic_JJ surveillance_NN pathway_NN in_IN humans_NNS
        is_VBZ underscored_VBN by_IN the_DT discovery_NN that_WDT mutated_VBN DNA_NNP damage_NN
        checkpoint_NN genes_NNS are_VBP associated_VBN with_IN an_DT increased_VBN incidence_NN
        of_IN cancer_NN [_NN 5_CD 6_CD 7_CD ]_NN ._.
        Many_JJ components_NNS of_IN the_DT DNA_NNP damage_NN checkpoint_NN have_VBP been_VBN
        isolated_VBN in_IN yeast_NN genetic_JJ screens_NNS designed_VBN to_TO identify_VB
        mutants_NNS that_WDT continued_JJ cell_NN cycle_NN progression_NN in_IN the_DT
        presence_NN of_IN DNA_NNP damage_NN [_NN 8_CD 9_CD 10_CD 11_CD 12_CD 13_CD 14_CD ]_NN ._. Combined_VBN
        with_IN recent_JJ genetic_JJ and_CC biochemical_JJ data_NNS ,_, it_PRP is_VBZ now_RB
        understood_VBN that_IN the_DT DNA_NNP damage_NN checkpoint_NN is_VBZ a_DT signal_NN
        transduction_NN cascade_NN containing_VBG sensor_NN ,_, transducer_NN and_CC
        receiver_NN proteins_NNS [_NN 15_CD ]_NN ._.
        In_IN fission_NN yeast_NN ,_, the_DT checkpoint_NN 
        rad_NN +_NN genes_NNS (_( 
        hus_JJ 1_CD +_NN ,_, 
        rad_NN 1_CD +_NN ,_, 
        rad_NN 3_CD +_NN ,_, 
        rad_NN 9_CD +_NN ,_, 
        rad_NN 17_CD +_NN and_CC 
        rad_NN 26_CD +_NN )_) and_CC 
        chk_NN 1_CD +_NN manage_VBP the_DT sensing_VBG and_CC
        transducing_VBG operations_NNS of_IN the_DT DNA_NNP damage_NN checkpoint_NN [_NN 1_CD 16_CD
        ]_NN ._. Current_JJ data_NNS suggest_VBP that_IN the_DT Rad_NNP 26_CD /_NN Rad_NNP 3_CD -_: kinase_NN complex_JJ
        initially_RB senses_NNS DNA_NNP damage_NN by_IN an_DT unknown_JJ mechanism_NN [_NN 17_CD ]_NN
        ._. This_DT response_NN leads_VBZ to_TO an_DT increase_NN in_IN the_DT kinase_NN activity_NN
        of_IN the_DT complex_JJ [_NN 18_CD ]_NN ,_, which_WDT phosphorylates_NNS and_CC activates_NNS
        the_DT transducing_VBG protein_NN kinase_NN ,_, Chk_NNP 1_CD [_NN 19_CD ]_NN ._. Finally_RB ,_, Chk_NNP 1_CD
        delays_NNS mitotic_JJ entry_NN by_IN targeting_VBG Cdc_NNP 25_CD and_CC Wee_NNP 1_CD ,_,
        regulators_NNS of_IN cyclin-dependent_JJ kinase_NN activity_NN [_NN 20_CD 21_CD 22_CD ]_NN
        ._.
        Hus_NNP 1_CD ,_, Rad_NNP 1_CD ,_, Rad_NNP 9_CD and_CC Rad_NNP 17_CD facilitate_VB
        Rad_NNP 26_CD /_NN Rad_NNP 3_CD -_: dependent_JJ phosphorylation_NN of_IN Chk_NNP 1_CD ._. For_IN instance_NN ,_,
        they_PRP are_VBP dispensable_JJ for_IN DNA_NNP damage-dependent_JJ activation_NN of_IN
        the_DT Rad_NNP 26_CD /_NN Rad_NNP 3_CD -_: kinase_NN complex_JJ [_NN 18_CD ]_NN ,_, but_CC are_VBP required_VBN for_IN
        the_DT Rad_NNP 3_CD -_: dependent_JJ phosphorylation_NN of_IN Chk_NNP 1_CD [_NN 23_CD ]_NN ._.
        Structural_NNP predictions_NNS of_IN Hus_NNP 1_CD ,_, Rad_NNP 1_CD and_CC Rad_NNP 9_CD have_VBP led_VBN to_TO
        the_DT proposal_NN that_IN all_DT three_CD fold_VB similarly_RB to_TO the_DT subunits_NNS
        of_IN Proliferating_NNP Cell_NNP Nuclear_NNP Antigen_NNP (_( PCNA_NNP )_) [_NN 24_CD 25_CD 26_CD ]_NN ._.
        Consistent_NNP with_IN these_DT predictions_NNS ,_, PCNA_NNP exists_VBZ as_IN a_DT
        homotrimer_NN [_NN 27_CD ]_NN while_IN Hus_NNP 1_CD ,_, Rad_NNP 1_CD and_CC Rad_NNP 9_CD all_DT interact_NN
        and_CC possibly_RB form_VB a_DT heterotrimer_NN [_NN 25_CD 28_CD ]_NN ._. In_IN addition_NN ,_,
        Rad_NNP 17_CD has_VBZ sequence_NN similarity_NN and_CC physical_JJ interactions_NNS
        with_IN subunits_NNS of_IN Replication_NNP Factor_NN C_NNP (_( RFC_NNP )_) [_NN 29_CD 30_CD ]_NN ._.
        Based_VBN on_IN the_DT RFC-PCNA_NNP paradigm_NN ,_, the_DT Rad_NNP 17_CD -_: RFC_NNP complex_JJ may_MD
        load_VB the_DT PCNA-like_NNP Rad_NNP 9_CD -_: Rad_NNP 1_CD -_: Hus_NNP 1_CD (_( 9_CD -_: 1_CD -_: 1_LS )_) complex_JJ onto_IN
        genomic_JJ lesions_NNS discovered_VBN by_IN the_DT Rad_NNP 26_CD /_NN Rad_NNP 3_CD complex_JJ ._. From_IN
        this_DT location_NN ,_, the_DT 9_CD -_: 1_CD -_: 1_CD complex_JJ may_MD link_VB the_DT Rad_NNP 26_CD /_NN Rad_NNP 3_CD
        complex_JJ with_IN Chk_NNP 1_CD ._.
        Rad_NNP 3_CD is_VBZ a_DT member_NN of_IN the_DT phosphoinositide_NN 3_CD -_: kinase_NN
        related_VBD kinase_NN (_( PIKK_NNP )_) family_NN [_NN 31_CD ]_NN ._. These_DT proteins_NNS are_VBP
        large_JJ (_( >_NN 200_CD kDa_NN )_) and_CC share_VB a_DT domain_NN related_VBN to_TO the_DT
        catalytic_JJ domain_NN of_IN phosphoinositide_NN 3_CD -_: kinases_NNS (_( PI-_NNP 3_CD
        kinases_NNS )_) ._. However_RB ,_, unlike_IN PI-_NNP 3_CD kinases_NNS ,_, PIKKs_NNP are_VBP not_RB known_VBN
        to_TO phosphorylate_NN lipids_NNS but_CC do_VBP possess_VBP protein_NN kinase_NN
        activity_NN ._. Other_JJ PIKK_NNP family_NN members_NNS also_RB function_VBP to_TO
        orchestrate_NN eukaryotic_JJ genotoxic_JJ stress_NN responses_NNS ,_,
        including_VBG human_JJ ATM_NNP ,_, ATR_NNP ,_, and_CC DNA-dependent_NNP protein_NN kinase_NN
        (_( DNA-PKcs_NNP )_) ,_, TEL_NNP 1_CD and_CC MEC_NNP 1_CD of_IN 
        Saccharomyces_NNP cerevisiae_NN ,_, Mei-_NNP 41_CD of_IN 
        Drosophila_NNP and_CC UVSB_NNP of_IN 
        Aspergillus_NNP nidulans_NNS [_NN 5_CD 32_CD 33_CD 34_CD ]_NN
        ._.
        Rad_NNP 26_CD is_VBZ a_DT regulatory_JJ subunit_NN of_IN the_DT Rad_NNP 26_CD /_NN Rad_NNP 3_CD complex_JJ
        that_WDT is_VBZ required_VBN for_IN Rad_NNP 3_CD kinase_NN activity_NN [_NN 18_CD ]_NN ._.
        Following_VBG DNA_NNP damage_NN ,_, Rad_NNP 26_CD undergoes_NNS Rad_NNP 3_CD -_: dependent_JJ
        phosphorylation_NN [_NN 17_CD ]_NN ._. Rad_NNP 26_CD is_VBZ a_DT 70_CD kDa_NN protein_NN
        containing_VBG little_RB informative_JJ sequence_NN information_NN beyond_IN a_DT
        predicted_VBN coiled-coil_JJ region_NN and_CC a_DT basic_JJ stretch_NN that_WDT
        resembles_VBZ a_DT nuclear_JJ localization_NN signal_NN [_NN 13_CD 32_CD ]_NN ._.
        Functionally_NNP conserved_JJ proteins_NNS with_IN very_RB weak_JJ sequence_NN
        similarity_NN have_VBP been_VBN found_VBN in_IN human_JJ (_( ATRIP_NNP )_) [_NN 35_CD ]_NN ,_, 
        S_NNP ._. cerevisiae_NN LCD_NNP 1_CD (_( aka_NN DDC_NNP 2_CD and_CC
        PIE_NNP 1_LS )_) [_NN 36_CD 37_CD 38_CD ]_NN and_CC 
        A_DT ._. nidulans_NNS (_( UVSD_NNP )_) [_NN 32_CD ]_NN ._.
        Rad_NNP 26_CD /_NN Rad_NNP 3_CD -_: like_IN complexes_NNS also_RB exist_VBP in_IN budding_VBG yeast_NN
        and_CC human_JJ ._. In_IN budding_VBG yeast_NN ,_, LCD_NNP 1_CD Rad_NNP 26_CD physically_RB interacts_NNS
        with_IN MEC_NNP 1_CD Rad_NNP 3_CD and_CC is_VBZ phosphorylated_JJ by_IN MEC_NNP 1_CD Rad_NNP 3_CD following_VBG
        DNA_NNP damage_NN [_NN 36_CD 37_CD ]_NN ._. Likewise_RB ,_, human_JJ ATRIP_NNP
        Rad_NNP 26_CD physically_RB interacts_NNS with_IN ATR_NNP Rad_NNP 3_CD and_CC also_RB undergoes_NNS
        DNA_NNP damage-dependent_JJ phosphorylation_NN by_IN ATR_NNP Rad_NNP 3_CD [_NN 35_CD ]_NN ._.
        However_RB ,_, Rad_NNP 26_CD is_VBZ required_VBN for_IN Rad_NNP 3_CD kinase_NN activity_NN in_IN
        fission_NN yeast_NN [_NN 18_CD ]_NN ,_, but_CC LCD_NNP 1_CD Rad_NNP 26_CD is_VBZ not_RB required_VBN for_IN
        MEC_NNP 1_CD Rad_NNP 3_CD kinase_NN activity_NN [_NN 38_CD ]_NN while_IN ATRIP_NNP Rad_NNP 26_CD is_VBZ
        required_VBN for_IN normal_JJ ATR_NNP Rad_NNP 3_CD expression_NN [_NN 35_CD ]_NN ._. Thus_RB ,_, the_DT
        role_NN of_IN the_DT Rad_NNP 26_CD -_: related_VBN proteins_NNS can_MD differ_VB among_IN
        organisms_NNS ._.
        The_DT checkpoint_NN system_NN in_IN fission_NN yeast_NN also_RB allows_VBZ cells_NNS
        to_TO recover_VB from_IN checkpoint-induced_JJ cell_NN cycle_NN arrest_NN [_NN 9_CD 39_CD
        40_CD ]_NN ._. Together_RB with_IN the_DT other_JJ Checkpoint_NNP Rad_NNP proteins_NNS ,_, the_DT
        Rad_NNP 26_CD /_NN Rad_NNP 3_CD complex_JJ controls_NNS this_DT genetically_RB defined_VBN
        pathway_NN that_IN likely_JJ regulates_VBZ DNA_NNP repair_NN activities_NNS ._. For_IN
        instance_NN ,_, 
        rad_NN 26_CD ._. T_NN 12_CD cells_NNS undergo_VBP
        checkpoint-induced_JJ cell_NN cycle_NN arrest_NN ,_, but_CC lose_VB viability_NN
        upon_IN re-entry_JJ into_IN the_DT cell_NN cycle_NN [_NN 40_CD ]_NN ._. The_DT 
        rad_NN 26_CD ._. T_NN 12_CD mutation_NN acts_NNS by_IN reducing_VBG
        the_DT stability_NN and_CC activity_NN of_IN the_DT Rad_NNP 26_CD /_NN Rad_NNP 3_CD checkpoint_NN
        complex_JJ [_NN 18_CD ]_NN ,_, suggesting_VBG that_DT cell_NN cycle_NN arrest_NN requires_VBZ
        only_RB a_DT pulse_NN of_IN Rad_NNP 26_CD /_NN Rad_NNP 3_CD kinase_NN activity_NN while_IN recovery_NN
        may_MD require_VB more_JJR ._. Therefore_RB ,_, quantitative_JJ differences_NNS in_IN
        the_DT kinase_NN activity_NN of_IN the_DT Rad_NNP 3_CD /_NN Rad_NNP 26_CD complex_JJ may_MD direct_VB
        the_DT cell_NN cycle_NN arrest_NN and_CC recovery_NN pathways_NNS ._.
        Here_RB ,_, we_PRP investigated_VBD how_WRB the_DT Rad_NNP 26_CD /_NN Rad_NNP 3_CD complex_JJ detects_NNS
        DNA_NNP damage_NN ._. Using_VBG a_DT Rad_NNP 26_CD -_: GFP_NNP fusion_NN protein_NN ,_, we_PRP found_VBD that_IN
        the_DT nuclei_NN of_IN cycling_NN cells_NNS contained_VBD ,_, on_IN average_JJ ,_, six_CD
        Rad_NNP 26_CD -_: GFP_NNP dots_NNS of_IN low_JJ fluorescent_NN intensity_NN ._. Combined_VBN with_IN
        our_PRP$ observations_NNS that_WDT 
        rad_NN 26_CD Δ_NN and_CC 
        rad_NN 3_CD Δ_NN cells_NNS are_VBP sensitive_JJ to_TO a_DT
        microtubule_NN depolymerizing_VBG drug_NN ,_, we_PRP speculate_VBP that_IN the_DT
        Rad_NNP 26_CD /_NN Rad_NNP 3_CD complex_JJ may_MD associate_JJ with_IN heterochromatin_NN ._.
        Following_VBG treatment_NN with_IN the_DT DNA_NNP damaging_JJ agent_NN
        Bleomycin_NNP ,_, we_PRP observed_VBD two_CD different_JJ patterns_NNS of_IN Rad_NNP 26_CD -_: GFP_NNP
        fluorescence_NN ._. Nearly_RB all_DT nuclei_NN (_( 95_CD %_NN )_) contained_VBD small_JJ ,_,
        numerous_JJ Rad_NNP 26_CD -_: GFP_NNP speckles_NNS ,_, and_CC roughly_RB 50_CD %_NN of_IN these_DT
        nuclei_NN also_RB contained_VBD one_CD or_CC two_CD very_RB bright_JJ Rad_NNP 26_CD -_: GFP_NNP
        spots_NNS ._. Results_NNS obtained_VBN with_IN a_DT Rad_NNP 26_CD ._. T_NN 12_CD -_: GFP_NNP fusion_NN protein_NN
        suggest_VBP that_IN the_DT speckles_NNS are_VBP linked_VBN to_TO repair_VB activities_NNS ,_,
        and_CC the_DT bright_JJ spots_NNS play_VBP a_DT role_NN in_IN checkpoint-dependent_JJ
        cell_NN cycle_NN arrest_NN ._. Furthermore_RB ,_, these_DT Rad_NNP 26_CD -_: GFP_NNP
        localization_NN patterns_NNS appeared_VBD normal_JJ in_IN 
        hus_JJ 1_CD Δ_NN ,_, 
        rad_NN 1_CD Δ_NN ,_, 
        rad_NN 9_CD Δ_NN ,_, 
        rad_NN 17_CD Δ_NN ,_, and_CC 
        rad_NN 3_CD Δ_NN backgrounds_NNS ._. Therefore_RB ,_, Rad_NNP 26_CD
        can_MD orchestrate_NN early_JJ events_NNS of_IN the_DT DNA_NNP damage_NN checkpoint_NN
        pathway_NN without_IN these_DT proteins_NNS ,_, including_VBG its_PRP$ catalytic_JJ
        partner_NN Rad_NNP 3_CD ._.
      
      
        Results_NNS
        
          Rad_NNP 26_CD -_: GFP_NNP Localizes_NNP to_TO a_DT small_JJ number_NN of_IN Nuclear_NNP
          Dots_NNP in_IN Cycling_NNP Cells_NNP
          Rad_NNP 26_CD is_VBZ a_DT regulatory_JJ subunit_NN of_IN the_DT Rad_NNP 3_CD checkpoint_NN
          kinase_NN [_NN 18_CD ]_NN ._. To_TO investigate_VB the_DT cellular_JJ distribution_NN
          of_IN Rad_NNP 26_CD ,_, we_PRP used_VBD a_DT one_CD step_NN PCR-based_NNP gene-modification_JJ
          method_NN [_NN 41_CD ]_NN to_TO fuse_NN GFP_NNP (_( S_NNP 65_CD T_NN )_) to_TO the_DT C-_NNP terminus_JJ of_IN the_DT
          genomic_JJ copy_NN of_IN rad_NN 26_CD +_NN ._. The_DT Rad_NNP 26_CD -_: GFP_NNP fusion_NN protein_NN
          maintained_VBD proper_JJ checkpoint_NN function_NN following_VBG
          hydroxyurea_NN (_( HU_NNP )_) and_CC Bleomycin_NNP treatments_NNS (_( data_NNS not_RB
          shown_VBN )_) ._.
          Since_IN the_DT background_NN fluorescence_NN in_IN live_VB ,_, cycling_NN
          cells_NNS was_VBD too_RB high_JJ to_TO derive_VB conclusions_NNS about_IN Rad_NNP 26_CD -_: GFP_NNP
          localization_NN (_( data_NNS not_RB shown_VBN )_) ,_, we_PRP prepared_VBD cells_NNS using_VBG a_DT
          technique_NN previously_RB described_VBD in_IN a_DT study_NN of_IN fission_NN
          yeast_NN chromatin_NN binding_JJ proteins_NNS [_NN 42_CD ]_NN ._. An_DT asynchronous_JJ
          population_NN of_IN cycling_NN cells_NNS was_VBD first_JJ permeabilized_JJ using_VBG
          Zymolyase_NNP (_( Seikagaku_NNP Corp_NNP ._. ,_, Tokyo_NNP )_) ,_, then_RB extracted_VBN with_IN
          1_CD %_NN Triton_NNP X-_NNP 100_CD and_CC finally_RB fixed_VBN with_IN methanol_NN ._. We_PRP did_VBD
          not_RB observe_VB GFP-fluorescence_NNP in_IN negative-control_JJ ,_, 
          rad_NN 26_CD +_NN cells_NNS (_( Figure_NN 1_CD A_DT )_) ._. However_RB ,_, 
          rad_NN 26_CD -_: GFP_NNP cells_NNS contained_VBD four_CD to_TO
          eight_CD nuclear_JJ GFP_NNP dots_NNS (_( six_CD on_IN average_JJ ,_, N_NNP =_SYM 100_CD ;_: Figure_NN
          1_CD B_NNP )_) ._. Non-extracted_NNP 
          rad_NN 26_CD -_: GFP_NNP cells_NNS ,_, prepared_VBN in_IN an_DT
          otherwise_RB identical_JJ manner_NN ,_, retained_VBD this_DT
          GFP-fluorescence_NNP pattern_NN (_( data_NNS not_RB shown_VBN )_) ._. We_PRP also_RB
          obtained_VBD similar_JJ results_NNS using_VBG paraformaldehyde_NN fixation_NN ,_,
          however_RB in_IN this_DT case_NN non-specific_JJ cytoplasmic_JJ background_NN
          fluorescence_NN was_VBD higher_JJR (_( data_NNS not_RB shown_VBN )_) ._.
        
        
          Rad_NNP 26_CD -_: GFP_NNP Localization_NNP in_IN Cycling_NNP Cells_NNP does_VBZ not_RB
          depend_VB on_IN Checkpoint_NNP Rad_NNP Proteins_NNPS
          Next_JJ ,_, we_PRP tested_VBD if_IN Rad_NNP 26_CD -_: GFP_NNP localization_NN to_TO dots_NNS in_IN
          cycling_NN cells_NNS depended_VBD upon_IN the_DT Checkpoint_NNP Rad_NNP proteins_NNS ._.
          The_DT 
          rad_NN 26_CD -_: GFP_NNP allele_NN was_VBD crossed_VBN into_IN
          five_CD checkpoint_NN 
          radΔ_NN alleles_NNS (_( 
          hus_JJ 1_CD Δ_NN ,_, 
          rad_NN 1_CD Δ_NN ,_, 
          rad_NN 9_CD Δ_NN ,_, 
          rad_NN 17_CD Δ_NN and_CC 
          rad_NN 3_CD Δ_NN )_) and_CC Rad_NNP 26_CD -_: GFP_NNP localization_NN
          was_VBD assayed_JJ in_IN Triton_NNP X-_NNP 100_CD extracted_VBN cells_NNS ._. None_NN of_IN the_DT
          checkpoint_NN 
          radΔ_NN alleles_NNS affected_VBD Rad_NNP 26_CD -_: GFP_NNP
          localization_NN in_IN cycling_NN cells_NNS ,_, although_IN we_PRP did_VBD observe_VB a_DT
          slight_JJ decrease_NN in_IN the_DT intensity_NN of_IN the_DT fluorescence_NN
          signal_NN in_IN these_DT genetic_JJ backgrounds_NNS (_( 
          rad_NN 9_CD Δ_NN ,_, rad_NN 26_CD -_: GFP_NNP cells_NNS are_VBP shown_VBN in_IN
          Figure_NN 1_CD C_NNP ;_: 
          hus_JJ 1_CD Δ_NN ,_, 
          rad_NN 1_CD Δ_NN ,_, 
          rad_NN 17_CD Δ_NN and_CC 
          rad_NN 3_CD Δ_NN cells_NNS containing_VBG 
          rad_NN 26_CD -_: GFP_NNP are_VBP not_RB shown_VBN )_) ._.
          Therefore_RB ,_, the_DT checkpoint_NN Rad_NNP proteins_NNS are_VBP not_RB required_VBN
          for_IN proper_JJ localization_NN of_IN Rad_NNP 26_CD -_: GFP_NNP in_IN cycling_NN
          cells_NNS ._.
        
        
          rad_NN 26_CD Δ_NN and_CC rad_NN 3_CD Δ_NN Share_NNP Sensitivity_NNP to_TO a_DT Microtubule_NNP
          De-polymerizing_NNP Drug_NNP
          Three_CD pieces_NNS of_IN evidence_NN suggest_VBP that_IN Checkpoint_NNP Rad_NNP
          proteins_NNS are_VBP physically_RB associated_VBN with_IN heterochromatin_NN ._.
          First_LS ,_, Rad_NNP 26_CD and_CC Rad_NNP 3_CD are_VBP required_VBN to_TO maintain_VB proper_JJ
          telomere_NN structure_NN and_CC telomere-associated_JJ gene_NN silencing_VBG
          [_NN 43_CD ]_NN ._. Second_JJ ,_, chromatin-immunoprecipitation_JJ (_( ChIP_NNP )_)
          experiments_NNS demonstrate_VBP that_IN over-expressed_JJ Rad_NNP 3_CD -_: HA_NNP
          exists_VBZ at_IN telomeres_NNS [_NN 44_CD ]_NN ._. Third_NNP ,_, Triton_NNP X-_NNP 100_CD
          extraction_NN ,_, shown_VBN previously_RB to_TO remove_VB non-chromatin_JJ
          bound_VBN proteins_NNS [_NN 42_CD ]_NN ,_, failed_VBD to_TO disrupt_VB the_DT Rad_NNP 26_CD -_: GFP_NNP
          dots_NNS in_IN the_DT nuclei_NN of_IN cycling_NN cells_NNS (_( see_VB Figure_NN 1_LS )_) ._.
          Physiological_NNP experiments_NNS can_MD also_RB be_VB used_VBN to_TO
          characterize_VB heterochromatin-binding_JJ proteins_NNS [_NN 45_CD ]_NN ._.
          For_IN example_NN ,_, absence_NN of_IN Swi_NNP 6_CD in_IN fission_NN yeast_NN sensitizes_NNS
          cells_NNS to_TO thiabendazole_NN (_( TBZ_NNP )_) ,_, a_DT microtubule_NN
          depolymerizing_VBG drug_NN [_NN 46_CD ]_NN ._. Presumably_RB this_DT occurs_VBZ
          because_IN absence_NN of_IN Swi_NNP 6_CD disrupts_NNS centromeric_JJ
          heterochromatin_NN and_CC ,_, as_IN a_DT result_NN ,_, sensitizes_NNS cells_NNS to_TO
          drugs_NNS that_WDT compromise_NN spindle_NN function_NN ._. To_TO test_VB whether_IN
          checkpoint_NN mutants_NNS are_VBP sensitive_JJ to_TO microtubule_NN
          depolymerization_NN drugs_NNS ,_, we_PRP spotted_VBD serial_NN dilutions_NNS of_IN
          cultures_NNS on_IN plates_NNS containing_VBG 20_CD mg_NN /_NN ml_NN TBZ_NNP ._. As_IN shown_VBN ,_,
          both_DT 
          rad_NN 26_CD Δ_NN and_CC 
          rad_NN 3_CD Δ_NN cells_NNS were_VBD sensitive_JJ to_TO TBZ_NNP
          (_( Figure_NN 2_LS )_) ._. Mutations_NNP that_WDT disrupt_VB the_DT microtubule_NN
          cytoskeleton_NN are_VBP also_RB known_VBN to_TO sensitize_VB cells_NNS to_TO TBZ_NNP [_NN
          47_CD ]_NN ._. However_RB ,_, using_VBG anti-tubulin_JJ immunofluorescence_NN ,_, we_PRP
          did_VBD not_RB discover_VB any_DT gross_JJ microtubule_NN cytoskeletal_NN
          abnormalities_NNS in_IN 
          rad_NN 26_CD Δ_NN and_CC 
          rad_NN 3_CD Δ_NN cells_NNS (_( data_NNS not_RB shown_VBN )_) ._. These_DT
          data_NNS lead_VBP us_PRP to_TO speculate_VB that_IN the_DT Rad_NNP 26_CD /_NN Rad_NNP 3_CD complex_JJ
          possibly_RB associates_NNS with_IN centromeric_JJ heterochromatin_NN in_IN
          cycling_NN cells_NNS ._. We_PRP are_VBP currently_RB testing_VBG this_DT
          hypothesis_NNS ._.
          Strains_NNP carrying_VBG the_DT 
          rad_NN 26_CD ._. T_NN 12_CD mutation_NN undergo_VBP cell_NN
          cycle_NN arrest_NN following_VBG treatment_NN with_IN a_DT DNA_NNP damage_NN agent_NN ,_,
          but_CC lose_VB viability_NN upon_IN re-entry_JJ into_IN the_DT cell_NN cycle_NN [_NN 13_CD
          40_CD ]_NN ._. We_PRP found_VBD that_IN the_DT 
          rad_NN 26_CD ._. T_NN 12_CD strain_NN is_VBZ significantly_RB
          less_RBR sensitive_JJ to_TO TBZ_NNP than_IN 
          rad_NN 26_CD Δ_NN and_CC 
          rad_NN 3_CD Δ_NN (_( Figure_NN 2_LS )_) ._. Therefore_RB ,_,
          deficiencies_NNS in_IN the_DT recovery_NN activities_NNS of_IN Rad_NNP 26_CD are_VBP not_RB
          related_VBN to_TO this_DT TBZ-phenotype_NNP ._.
        
        
          Checkpoint_NNP rad_NN mutants_NNS do_VBP not_RB share_VB TBZ_NNP
          Sensitivity_NNP
          Next_JJ ,_, we_PRP tested_VBD if_IN the_DT four_CD other_JJ checkpoint_NN 
          radΔ_NN alleles_NNS (_( 
          hus_JJ 1_CD Δ_NN ,_, rad_NN 1_CD Δ_NN ,_, rad_NN 9_CD Δ_NN and_CC 
          rad_NN 17_CD Δ_NN )_) conferred_VBD TBZ_NNP sensitivity_NN
          (_( Figure_NN 3_LS )_) ._. Interestingly_RB ,_, 
          rad_NN 9_CD Δ_NN and_CC 
          rad_NN 1_CD Δ_NN ,_, but_CC not_RB 
          rad_NN 17_CD Δ_NN and_CC 
          hus_JJ 1_CD Δ_NN ,_, shared_VBD this_DT phenotype_NN ._.
          Since_IN each_DT of_IN the_DT checkpoint_NN 
          rads_NNS is_VBZ an_DT essential_JJ component_NN of_IN
          the_DT checkpoint_NN ,_, TBZ_NNP sensitivity_NN can_MD not_RB be_VB the_DT indirect_JJ
          result_NN of_IN defects_NNS in_IN the_DT checkpoint_NN response_NN ._.
          The_DT kinase_NN activity_NN of_IN Rad_NNP 3_CD is_VBZ essential_JJ for_IN
          checkpoint_NN signaling_VBG and_CC is_VBZ the_DT only_RB known_VBN biochemical_JJ
          function_NN of_IN this_DT 220_CD kDa_NN protein_NN [_NN 48_CD 49_CD ]_NN ._. The_DT 
          rad_NN 3_CD ._. a_DT strain_NN has_VBZ an_DT amino_JJ acid_NN
          change_NN (_( D_NNP 2230_CD A_DT )_) in_IN the_DT conserved_JJ kinase_NN domain_NN of_IN Rad_NNP 3_CD
          that_WDT eliminates_VBZ cell_NN cycle_NN arrest_NN in_IN response_NN to_TO DNA_NNP
          damaging_JJ agents_NNS [_NN 48_CD 49_CD ]_NN ._. Interestingly_RB ,_, we_PRP found_VBD that_IN
          the_DT 
          rad_NN 3_CD ._. a_DT strain_NN is_VBZ less_RBR sensitive_JJ to_TO
          TBZ_NNP than_IN the_DT 
          rad_NN 3_CD Δ_NN and_CC 
          rad_NN 26_CD Δ_NN strains_NNS (_( Figure_NN 4_LS )_) ._.
          Therefore_RB ,_, TBZ_NNP sensitivity_NN is_VBZ caused_VBN by_IN more_JJR than_IN loss_NN of_IN
          Rad_NNP 3_CD -_: kinase_NN activity_NN alone_RB ._.
        
        
          Rad_NNP 26_CD -_: GFP_NNP Spots_NNS and_CC Speckles_NNP Form_NNP in_IN Response_NNP to_TO
          DNA_NNP Damage_NN
          To_TO test_VB if_IN Rad_NNP 26_CD -_: GFP_NNP localization_NN changes_NNS in_IN response_NN
          to_TO DNA_NNP damage_NN ,_, a_DT culture_NN of_IN 
          rad_NN 26_CD -_: GFP_NNP cells_NNS was_VBD grown_VBN to_TO
          mid-log_JJ phase_NN (_( optical_JJ density_NN 0_CD ._. 3_LS )_) and_CC then_RB treated_VBN with_IN
          Bleomycin_NNP ,_, a_DT radiomimetic_JJ drug_NN ,_, for_IN 3_CD hours_NNS before_IN
          fixation_NN and_CC DAPI_NNP staining_VBG ._. The_DT 
          rad_NN 26_CD -_: GFP_NNP cells_NNS underwent_VBD a_DT normal_JJ ,_,
          checkpoint_NN response_NN following_VBG Bleomycin_NNP treatment_NN and_CC
          arrested_VBN cell_NN cycle_NN progression_NN with_IN one_CD nucleus_NN in_IN a_DT
          long_JJ cell_NN (_( Figure_NN 5_CD A_DT )_) ._. We_PRP observed_VBD two_CD distinct_JJ patterns_NNS
          of_IN GFP-fluorescence_NNP in_IN these_DT treated_VBN cells_NNS ._. First_LS ,_, nearly_RB
          every_DT cell_NN (_( 95_CD %_NN )_) contained_VBD many_JJ small_JJ foci_NN that_IN we_PRP call_VBP
          speckles_NNS (_( Figure_NN 5_CD A_DT )_) ._. These_DT speckles_NNS are_VBP different_JJ than_IN
          the_DT larger_JJR ,_, less_RBR numerous_JJ dots_NNS (_( 6_CD on_IN average_JJ )_) that_IN we_PRP
          observed_VBD in_IN untreated_JJ ,_, cycling_NN cells_NNS (_( compare_VB Figure_NN
          1_CD Bwith_NNP Figure_NNP 5_CD A_DT )_) ._. Second_JJ ,_, approximately_RB half_NN of_IN
          Bleomycin-treated_NNP cells_NNS also_RB contained_VBD one_CD or_CC two_CD bright_JJ ,_,
          nuclear_JJ spots_NNS (_( Figure_NN 5_CD B_NNP ;_: arrow_NN denotes_NNS the_DT speckles_NNS that_WDT
          formed_VBD in_IN these_DT cells_NNS )_) ._. We_PRP found_VBD that_IN 2_CD %_NN of_IN untreated_JJ ,_,
          cycling_NN rad_NN 26_CD -_: GFP_NNP cells_NNS contained_VBD one_CD or_CC two_CD Rad_NNP 26_CD -_: GFP_NNP
          spots_NNS ,_, while_IN 55_CD %_NN of_IN Bleomycin_NNP treated_VBD ,_, 
          rad_NN 26_CD -_: GFP_NNP cells_NNS formed_VBD these_DT spots_NNS
          (_( Figure_NN 6_CD )_) ._. Since_IN we_PRP also_RB observed_VBD these_DT spots_NNS in_IN live_VB ,_,
          Bleomycin-treated_NNP 
          rad_NN 26_CD -_: GFP_NNP cells_NNS (_( data_NNS not_RB shown_VBN )_) ,_,
          these_DT results_NNS were_VBD not_RB affected_VBN by_IN methanol_NN fixation_NN ._.
          Furthermore_RB ,_, both_DT spots_NNS and_CC speckles_NNS formed_VBN within_IN 30_CD
          minutes_NNS of_IN Bleomycin_NNP addition_NN (_( data_NNS not_RB shown_VBN )_) ._. These_DT
          data_NNS show_VBP that_IN speckles_NNS and_CC one_CD or_CC two_CD bright_JJ ,_, nuclear_JJ
          Rad_NNP 26_CD -_: GFP_NNP spots_NNS form_VBP in_IN Bleomycin-treated_NNP cells_NNS ._.
          These_DT changes_NNS in_IN Rad_NNP 26_CD -_: GFP_NNP localization_NN could_MD be_VB a_DT
          direct_JJ response_NN to_TO the_DT DNA_NNP damage_NN caused_VBN by_IN Bleomycin_NNP
          treatment_NN ,_, or_CC an_DT indirect_JJ consequence_NN of_IN G_NNP 2_CD /_NN M_NNP cell_NN cycle_NN
          arrest_NN that_WDT occurs_VBZ after_IN checkpoint-activation_JJ ._. The_DT 
          cdc_NN 25_CD +_NN gene_NN encodes_NNS a_DT positive_JJ
          mitotic_JJ regulator_NN [_NN 50_CD ]_NN that_WDT is_VBZ also_RB a_DT target_NN of_IN DNA_NNP
          damage_NN checkpoint_NN signaling_VBG [_NN 51_CD ]_NN ._. At_IN the_DT restrictive_JJ
          temperature_NN (_( 37_CD °_NN C_NNP )_) ,_, the_DT temperature-sensitive_JJ 
          cdc_NN 25_CD ._. 22_CD allele_NN causes_VBZ cells_NNS to_TO
          arrest_VB at_IN the_DT G_NNP 2_CD /_NN M_NNP boundary_NN [_NN 52_CD ]_NN ._. To_TO test_VB if_IN these_DT
          Bleomycin-induced_NNP patterns_NNS of_IN Rad_NNP 26_CD -_: GFP_NNP fluorescence_NN
          formed_VBN as_IN an_DT indirect_JJ consequence_NN of_IN cell_NN cycle_NN arrest_NN ,_,
          we_PRP crossed_VBD the_DT 
          cdc_NN 25_CD ._. 22_CD mutation_NN into_IN a_DT 
          rad_NN 26_CD -_: GFP_NNP background_NN ._. A_DT 
          cdc_NN 25_CD ._. 22_CD rad_NN 26_CD -_: GFP_NNP strain_NN was_VBD
          isolated_VBN and_CC grown_VBN to_TO mid-log_JJ phase_NN before_IN shifting_VBG to_TO
          the_DT restrictive_JJ temperature_NN for_IN 3_CD hours_NNS ._. This_DT caused_VBD the_DT
          cells_NNS to_TO arrest_VB cell_NN cycle_NN progression_NN with_IN a_DT single_JJ
          nucleus_NN in_IN a_DT long_JJ cell_NN (_( data_NNS not_RB shown_VBN )_) ,_, but_CC did_VBD not_RB
          increase_VB the_DT formation_NN of_IN Rad_NNP 26_CD -_: GFP_NNP spots_NNS (_( Figure_NN 6_CD )_) or_CC
          speckles_NNS (_( data_NNS not_RB shown_VBN )_) ._. These_DT data_NNS suggest_VBP that_IN both_DT
          patterns_NNS of_IN Rad_NNP 26_CD -_: GFP_NNP fluorescence_NN (_( spots_NNS and_CC speckles_NNS )_)
          occur_VB as_IN a_DT result_NN of_IN DNA_NNP damage_NN ,_, as_IN opposed_VBN to_TO the_DT
          checkpoint-induced_JJ G_NNP 2_CD /_NN M_NNP cell_NN cycle_NN delay_NN that_WDT follows_VBZ
          Bleomycin_NNP treatment_NN ._.
        
        
          Formation_NNP of_IN Rad_NNP 26_CD -_: GFP_NNP Spots_NNS and_CC Speckles_NNP after_IN DNA_NNP
          Damage_NN does_VBZ not_RB require_VB Other_NNP Checkpoint_NNP Rad_NNP
          Proteins_NNPS
          Next_JJ ,_, we_PRP tested_VBD if_IN these_DT patterns_NNS of_IN Rad_NNP 26_CD -_: GFP_NNP
          fluorescence_NN formed_VBN in_IN other_JJ checkpoint_NN 
          radΔ_NN cells_NNS ._. Similar_JJ to_TO results_NNS
          obtained_VBN in_IN a_DT wild-type_JJ background_NN ,_, we_PRP observed_VBD that_IN
          between_IN 48_CD %_NN and_CC 56_CD %_NN of_IN checkpoint_NN 
          radΔ_NN cells_NNS formed_VBD one_CD or_CC two_CD
          bright_JJ ,_, Rad_NNP 26_CD -_: GFP_NNP spots_NNS following_VBG Bleomycin_NNP treatment_NN
          (_( Figures_NNS 5_CD Cand_NNP 7_CD )_) ._. We_PRP also_RB observed_VBD that_IN some_DT of_IN these_DT
          cells_NNS contained_VBD Rad_NNP 26_CD -_: GFP_NNP speckles_NNS (_( arrow_NN in_IN Figure_NN 5_CD C_NNP )_) ._.
          However_RB ,_, the_DT Rad_NNP 26_CD -_: GFP_NNP signal_NN in_IN 
          radΔ_NN cells_NNS was_VBD slightly_RB weaker_JJR than_IN
          what_WP we_PRP observed_VBD in_IN a_DT 
          rad_NN +_NN background_NN (_( compare_VB Figure_NN
          5_CD Cwith_NNP 5_CD A_DT and_CC 5_CD B_NNP )_) ,_, and_CC we_PRP were_VBD unable_JJ to_TO confidently_RB
          determine_VB the_DT efficiency_NN by_IN which_WDT 
          radΔ_NN cells_NNS formed_VBD Rad_NNP 26_CD -_: GFP_NNP
          speckles_NNS following_VBG DNA_NNP damage_NN ._.
          An_DT elevated_VBD number_NN of_IN untreated_JJ ,_, cycling_NN checkpoint_NN 
          radΔ_NN cells_NNS contained_VBD one_CD or_CC two_CD
          bright_JJ Rad_NNP 26_CD -_: GFP_NNP spots_NNS ._. While_IN 2_CD %_NN of_IN untreated_JJ 
          rad_NN 26_CD -_: GFP_NNP cells_NNS contained_VBD these_DT
          spots_NNS ,_, between_IN 3_CD %_NN and_CC 7_CD %_NN of_IN untreated_JJ ,_, checkpoint_NN 
          radΔ_NN cells_NNS formed_VBD them_PRP (_( Figure_NN 7_CD )_) ._.
          The_DT spots_NNS may_MD form_VB in_IN response_NN to_TO spontaneous_JJ DNA_NNP damage_NN
          that_WDT can_MD arise_VB during_IN a_DT typical_JJ cell_NN cycle_NN ,_, and_CC the_DT
          absence_NN of_IN Hus_NNP 1_CD ,_, Rad_NNP 1_CD ,_, Rad_NNP 3_CD ,_, Rad_NNP 9_CD or_CC Rad_NNP 17_CD may_MD increase_VB
          these_DT events_NNS ._.
          We_PRP also_RB tested_VBD if_IN Rad_NNP 3_CD kinase_NN activity_NN was_VBD required_VBN
          for_IN re-localization_JJ of_IN Rad_NNP 26_CD -_: GFP_NNP following_VBG Bleomycin_NNP
          treatment_NN ._. However_RB ,_, neither_DT the_DT 
          rad_NN 3_CD ._. a_DT nor_CC a_DT 
          rad_NN 3_CD Δ_NN allele_NN significantly_RB affected_VBD
          the_DT ability_NN of_IN Rad_NNP 26_CD -_: GFP_NNP to_TO form_VB the_DT bright_JJ foci_NN
          following_VBG Bleomycin_NNP treatment_NN (_( Figure_NN 8_CD )_) ._. Therefore_RB ,_,
          Rad_NNP 26_CD can_MD respond_VB to_TO DNA_NNP damage_NN in_IN the_DT absence_NN of_IN
          Rad_NNP 3_CD ._.
        
        
          Rad_NNP 26_CD -_: GFP_NNP Spots_NNS are_VBP Associated_NNP with_IN Cell_NNP Cycle_NNP
          Arrest_NN ,_, and_CC Speckles_NNP are_VBP Associated_NNP with_IN Recovery_NNP
          Rad_NNP 26_CD functions_NNS in_IN checkpoint_NN cell_NN cycle_NN arrest_NN and_CC
          recovery_NN pathways_NNS ._. A_DT mutant_JJ allele_NN ,_, 
          rad_NN 26_CD ._. T_NN 12_CD ,_, genetically_RB separates_NNS
          these_DT functions_NNS ,_, since_IN 
          rad_NN 26_CD ._. T_NN 12_CD cells_NNS can_MD undergo_VB
          checkpoint-induced_JJ cell_NN cycle_NN arrest_NN but_CC fail_VB to_TO recover_VB
          and_CC lose_VB viability_NN [_NN 13_CD 40_CD ]_NN ._. To_TO determine_VB if_IN spots_NNS and_CC
          speckles_NNS are_VBP associated_VBN with_IN these_DT different_JJ Rad_NNP 26_CD
          functions_NNS ,_, we_PRP tagged_VBN the_DT C-_NNP terminus_JJ of_IN Rad_NNP 26_CD ._. T_NN 12_CD with_IN GFP_NNP
          using_VBG the_DT same_JJ primers_NNS and_CC method_NN that_IN we_PRP used_VBD to_TO tag_VB
          Rad_NNP 26_CD (_( see_VB Methods_NNP )_) ._. After_IN confirming_VBG that_IN the_DT 
          rad_NN 26_CD ._. T_NN 12_CD -_: GFP_NNP strain_NN behaved_VBD
          similarly_RB to_TO a_DT 
          rad_NN 26_CD ._. T_NN 12_CD strain_NN in_IN response_NN to_TO
          both_DT Bleomycin_NNP and_CC HU_NNP (_( data_NNS not_RB shown_VBN )_) ,_, we_PRP investigated_VBD
          Rad_NNP 26_CD ._. T_NN 12_CD -_: GFP_NNP localization_NN following_VBG Bleomycin_NNP treatment_NN ._.
          We_PRP observed_VBD that_IN bright_JJ spots_NNS formed_VBN in_IN both_DT 
          rad_NN 26_CD -_: GFP_NNP and_CC 
          rad_NN 26_CD ._. T_NN 12_CD -_: GFP_NNP cells_NNS that_WDT had_VBD been_VBN
          extracted_VBN with_IN Triton_NNP X-_NNP 100_CD prior_RB to_TO microscopy_NN (_( Figure_NN
          9_CD ,_, Figure_NN 10_CD Aand_NNP 10_CD B_NNP )_) ._. We_PRP also_RB observed_VBD speckles_NNS in_IN 
          rad_NN 26_CD -_: GFP_NNP cells_NNS (_( Figure_NN 10_CD A_DT )_) but_CC
          did_VBD not_RB identify_VB these_DT structures_NNS in_IN Bleomycin-treated_NNP 
          rad_NN 26_CD ._. T_NN 12_CD -_: GFP_NNP cells_NNS (_( Figure_NN 10_CD B_NNP )_) ._.
          Likewise_RB ,_, both_DT spots_NNS and_CC speckles_NNS formed_VBN in_IN
          paraformaldehyde-fixed_JJ 
          rad_NN 26_CD -_: GFP_NNP cells_NNS ,_, while_IN only_JJ spots_VBZ
          formed_VBN in_IN 
          rad_NN 26_CD ._. T_NN 12_CD -_: GFP_NNP cells_NNS (_( Figure_NN 10_CD C_NNP )_) ._.
          These_DT data_NNS link_VBP the_DT bright_JJ ,_, Rad_NNP 26_CD -_: GFP_NNP spots_NNS with_IN the_DT cell_NN
          cycle_NN arrest_NN activities_NNS of_IN the_DT DNA_NNP damage_NN checkpoint_NN ,_, and_CC
          suggest_VBP that_IN Rad_NNP 26_CD -_: GFP_NNP speckles_NNS play_VBP a_DT role_NN in_IN
          recovery_NN ._.
        
      
      
        Discussion_NNP
        
          Dots_NNP ,_, spots_VBZ and_CC speckles_NNS :_: cytology_NN of_IN
          Rad_NNP 26_CD -_: GFP_NNP
          The_DT Rad_NNP 26_CD /_NN Rad_NNP 3_CD complex_JJ plays_VBZ a_DT critical_JJ role_NN in_IN the_DT
          checkpoint_NN response_NN to_TO DNA_NNP damage_NN in_IN fission_NN yeast_NN ._. Here_RB ,_,
          we_PRP studied_VBD the_DT cytological_JJ events_NNS that_WDT may_MD be_VB associated_VBN
          with_IN these_DT functions_NNS of_IN the_DT complex_NN ._.
          In_IN normal_JJ cycling_NN cells_NNS ,_, Rad_NNP 26_CD -_: GFP_NNP localized_VBN to_TO
          between_IN 4_CD -_: 8_CD dots_NNS (_( Figure_NN 1_CD B_NNP )_) ._. After_IN DNA_NNP damage_NN ,_,
          Rad_NNP 26_CD -_: GFP_NNP localized_VBN to_TO numerous_JJ smaller_JJR foci_NN called_VBD
          speckles_NNS (_( compare_VB Figures_NNS 1_CD Band_NNP 5_CD A_DT )_) ._. Approximately_RB half_NN
          of_IN these_DT damaged_JJ cells_NNS also_RB contained_VBD one_CD or_CC two_CD bright_JJ
          Rad_NNP 26_CD -_: GFP_NNP spots_NNS (_( Figure_NN 5_CD B_NNP )_) ._. In_IN this_DT discussion_NN we_PRP
          consider_VBP the_DT location_NN and_CC function_NN of_IN these_DT distinct_JJ ,_,
          cytological_JJ structures_NNS ._.
        
        
          Dots_NNP :_: Rad_NNP 26_CD -_: GFP_NNP localization_NN in_IN normal_JJ cycling_NN
          cells_NNS
          For_IN technical_JJ reasons_NNS we_PRP were_VBD unable_JJ to_TO conclusively_RB
          identify_VB these_DT structures_NNS (_( Figure_NN 1_CD B_NNP )_) ,_, but_CC for_IN a_DT number_NN
          of_IN reasons_NNS we_PRP believe_VBP that_IN they_PRP may_MD be_VB associated_VBN with_IN
          sites_NNS of_IN heterochromatin_NN ._. First_LS ,_, the_DT Rad_NNP 26_CD -_: GFP_NNP dots_NNS were_VBD
          resistant_JJ to_TO an_DT extraction_NN method_NN that_WDT was_VBD developed_VBN to_TO
          specifically-preserve_JJ the_DT localization_NN of_IN
          chromatin-binding_JJ proteins_NNS [_NN 42_CD ]_NN ._. Secondly_RB ,_, we_PRP
          discovered_VBD that_IN the_DT 
          rad_NN 26_CD Δ_NN strain_NN is_VBZ sensitive_JJ to_TO TBZ_NNP ,_,
          a_DT phenotype_NN common_JJ to_TO mutants_NNS that_WDT disrupt_VB
          centromeric-heterochromatin_JJ [_NN 45_CD ]_NN ._. Finally_RB ,_, fission_NN
          yeast_NN has_VBZ a_DT relatively_RB small_JJ number_NN of_IN heterochromatic_JJ
          regions_NNS (_( 3_CD centromeres_NNS ,_, 6_CD telomeres_NNS ,_, and_CC 1_CD mating-type_JJ
          locus_JJ ;_: [_NN 53_CD 54_CD ]_NN )_) and_CC the_DT number_NN of_IN Rad_NNP 26_CD -_: GFP_NNP dots_NNS we_PRP
          observe_VBP is_VBZ roughly_RB consistent_JJ with_IN localization_NN to_TO these_DT
          regions_NNS ._. In_IN addition_NN ,_, other_JJ studies_NNS have_VBP revealed_VBN a_DT
          functional_JJ role_NN for_IN checkpoint_NN Rad_NNP proteins_NNS in_IN telomere_NN
          maintenance_NN [_NN 43_CD 44_CD ]_NN ,_, while_IN one_CD has_VBZ shown_VBN that_IN an_DT
          over-expressed_JJ ,_, epitope_NN tagged_VBN version_NN of_IN Rad_NNP 3_CD associates_NNS
          with_IN telomeric_JJ DNA_NNP [_NN 44_CD ]_NN ._. It_PRP will_MD be_VB interesting_JJ to_TO
          determine_VB if_IN checkpoint_NN proteins_NNS have_VBP a_DT role_NN in_IN
          centromere_NN function_NN ,_, or_CC mating-type_JJ silencing_VBG ,_, both_DT of_IN
          which_WDT require_VBP intact_JJ heterochromatic_JJ structures_NNS ._.
          Alternative_NNP explanations_NNS exist_VBP ._. For_IN example_NN ,_, the_DT
          microtubule_NN cytoskeleton_NN has_VBZ been_VBN implicated_VBN in_IN
          recombination-dependent_JJ DNA_NNP repair_NN processes_VBZ in_IN budding_VBG
          yeast_NN [_NN 55_CD ]_NN ._. The_DT TBZ-sensitivity_NNP of_IN DNA_NNP damage_NN
          checkpoint_NN mutants_NNS ,_, such_JJ as_IN 
          rad_NN 26_CD Δ_NN and_CC 
          rad_NN 3_CD Δ_NN ,_, may_MD indicate_VB that_IN
          checkpoint_NN proteins_NNS cooperate_VBP with_IN the_DT cytoskeleton_NN
          during_IN such_JJ repair_NN ._.
        
        
          TBZ_NNP sensitivity_NN reveals_VBZ novel_NN aspects_NNS of_IN checkpoint_NN
          Rad_NNP protein_NN function_NN
          The_DT TBZ_NNP sensitivity_NN assay_NN identifies_VBZ distinct_JJ
          functions_NNS of_IN checkpoint_NN Rad_NNP proteins_NNS ._. In_IN particular_JJ ,_, 
          rad_NN 1_CD Δ_NN and_CC 
          rad_NN 9_CD Δ_NN are_VBP also_RB sensitive_JJ to_TO TBZ_NNP ,_,
          while_IN 
          rad_NN 17_CD Δ_NN and_CC 
          hus_JJ 1_CD Δ_NN are_VBP not_RB (_( Figure_NN 3_LS )_) ._. Studies_NNS
          suggest_VBP that_IN Hus_NNP 1_CD ,_, Rad_NNP 1_CD ,_, and_CC Rad_NNP 9_CD function_NN together_RB to_TO
          form_VB a_DT PCNA-like_NNP clamp_NN complex_JJ that_WDT is_VBZ loaded_VBN onto_IN DNA_NNP by_IN
          Rad_NNP 17_CD [_NN 16_CD ]_NN ._. This_DT model_NN predicts_VBZ that_IN all_DT four_CD proteins_NNS
          should_MD show_VB the_DT same_JJ levels_NNS of_IN TBZ_NNP sensitivity_NN since_IN
          deletion_NN of_IN any_DT of_IN the_DT four_CD proteins_NNS should_MD prevent_VB
          formation_NN of_IN a_DT functional_JJ clamp_NN ._. The_DT TBZ-data_NNP shown_VBN here_RB
          suggest_VBP that_IN at_IN least_JJS Rad_NNP 1_CD and_CC Rad_NNP 9_CD have_VBP roles_NNS that_WDT are_VBP
          independent_JJ of_IN their_PRP$ function_NN in_IN the_DT PCNA-like_NNP clamp_NN ._.
          In_IN addition_NN ,_, we_PRP found_VBD that_DT 
          rad_NN 3_CD ._. a_DT ,_, a_DT mutation_NN that_IN disrupts_NNS
          Rad_NNP 3_CD kinase_NN activity_NN ,_, confers_VBZ less_JJR TBZ_NNP sensitivity_NN than_IN a_DT
          
          rad_NN 3_CD Δ_NN allele_NN (_( Figure_NN 4_LS )_) ._. To_TO our_PRP$
          knowledge_NN ,_, this_DT is_VBZ the_DT first_JJ study_NN to_TO detect_VB
          physiological_JJ differences_NNS between_IN a_DT kinase-dead_JJ allele_NN of_IN
          
          rad_NN 3_CD +_NN and_CC a_DT full_JJ deletion_NN ._. This_DT
          demonstrates_VBZ that_IN Rad_NNP 3_CD has_VBZ a_DT biochemical_JJ activity_NN in_IN
          addition_NN to_TO its_PRP$ catalytic_JJ kinase_NN activity_NN ._.
          TBZ_NNP sensitivity_NN may_MD reveal_VB a_DT novel_NN role_NN for_IN checkpoint_NN
          Rad_NNP proteins_NNS that_WDT is_VBZ independent_JJ of_IN the_DT DNA_NNP damage_NN
          checkpoint_NN response_NN ._. Alternatively_RB ,_, some_DT structure_NN that_WDT
          is_VBZ required_VBN to_TO prevent_VB TBZ_NNP sensitivity_NN ,_, such_JJ as_IN
          centromeric_JJ heterochromatin_NN ,_, may_MD function_VB in_IN checkpoint_NN
          control_NN ._. Possibly_RB ,_, the_DT Rad_NNP 26_CD /_NN Rad_NNP 3_CD complex_JJ localizes_NNS to_TO
          regions_NNS of_IN heterochromatin_NN (_( centromeres_NNS ,_, telomeres_NNS and_CC
          the_DT mating_NN type_NN loci_NN )_) in_IN undamaged_JJ cells_NNS ._. From_IN these_DT
          vantage_NN points_NNS ,_, the_DT Rad_NNP 26_CD /_NN Rad_NNP 3_CD complex_JJ may_MD survey_VB the_DT
          entire_JJ genome_NN for_IN DNA_NNP damage_NN ._. For_IN example_NN ,_,
          heterochromatin_NN functions_NNS in_IN the_DT organization_NN of_IN
          chromatin_NN ,_, the_DT cohesive_JJ force_NN existing_VBG between_IN
          chromatids_NNS ,_, and_CC the_DT tension_NN on_IN chromosomes_NNS produced_VBN by_IN
          the_DT spindle_NN apparatus_NN [_NN 56_CD 57_CD ]_NN ._. DNA_NNP damage_NN may_MD produce_VB
          changes_NNS in_IN these_DT elements_NNS ._. By_IN localizing_VBG to_TO
          heterochromatic_JJ regions_NNS ,_, the_DT Rad_NNP 26_CD /_NN Rad_NNP 3_CD complex_JJ possibly_RB
          monitors_VBZ such_JJ elements_NNS to_TO perceive_VBP DNA_NNP damage_NN on_IN a_DT
          genome-wide_JJ scale_NN ._.
        
        
          Spots_NNS and_CC Speckles_NNP :_: localization_NN of_IN Rad_NNP 26_CD -_: GFP_NNP in_IN
          response_NN to_TO DNA_NNP damage_NN
          Within_IN thirty_CD minutes_NNS of_IN Bleomycin_NNP treatment_NN ,_, the_DT
          Rad_NNP 26_CD -_: GFP_NNP dots_NNS found_VBD in_IN cycling_NN cells_NNS were_VBD replaced_VBN by_IN
          speckles_NNS and_CC spots_NNS (_( Figures_NNS 5_CD Aand_NNP 5_CD B_NNP )_) ._. Both_DT of_IN these_DT
          Rad_NNP 26_CD -_: GFP_NNP patterns_NNS were_VBD absent_JJ from_IN G_NNP 2_CD /_NN M_NNP arrested_VBD 
          cdc_NN 25_CD ._. 22_CD rad_NN 26_CD -_: GFP_NNP cells_NNS (_( Figure_NN
          6_CD )_) ,_, so_IN they_PRP likely_RB resulted_VBD from_IN Bleomycin-induced_NNP DNA_NNP
          damage_NN as_IN opposed_VBN to_TO checkpoint-induced_JJ cell_NN cycle_NN
          arrest_NN ._. Also_RB ,_, both_DT types_NNS of_IN Rad_NNP 26_CD -_: GFP_NNP patterns_NNS formed_VBN
          independently_RB of_IN the_DT other_JJ checkpoint_NN Rad_NNP proteins_NNS
          (_( Figures_NNS 5_CD Cand_NNP 7_CD )_) ,_, and_CC did_VBD not_RB require_VB Rad_NNP 3_CD kinase_NN
          activity_NN or_CC Rad_NNP 3_CD (_( Figure_NN 8_CD )_) ._. Together_RB ,_, these_DT analyses_NNS
          suggest_VBP that_IN the_DT cytological_JJ changes_NNS of_IN Rad_NNP 26_CD -_: GFP_NNP are_VBP
          very_RB early_JJ steps_NNS in_IN the_DT process_NN of_IN checkpoint_NN activation_NN
          that_WDT are_VBP directed_VBN entirely_RB by_IN Rad_NNP 26_CD ._.
          Interestingly_RB ,_, speckle_NN formation_NN was_VBD compromised_VBN in_IN
          Bleomycin-treated_NNP 
          rad_NN 26_CD ._. T_NN 12_CD -_: GFP_NNP cells_NNS ,_, which_WDT are_VBP cell_NN
          cycle_NN arrest-proficient_JJ but_CC recovery-deficient_JJ (_( Figure_NN
          10_CD )_) ._. In_IN contrast_NN ,_, formation_NN of_IN the_DT Rad_NNP 26_CD ._. T_NN 12_CD -_: GFP_NNP spots_NNS
          occurred_VBD normally_RB after_IN Bleomycin-treatment_NNP (_( Figures_NNS 9_CD and_CC
          10_CD )_) ._. These_DT results_NNS suggest_VBP that_IN the_DT speckles_NNS could_MD be_VB
          associated_VBN with_IN DNA_NNP repair_NN and_CC recovery_NN activities_NNS ,_, while_IN
          the_DT spots_NNS could_MD be_VB associated_VBN with_IN cell_NN cycle_NN arrest_NN ._.
          Following_VBG ultraviolet_NN radiation_NN of_IN HeLa_NNP cells_NNS ,_,
          paraformaldehyde_NN fixation_NN and_CC Triton_NNP X-_NNP 100_CD extraction_NN ,_,
          Cortez_NNP 
          et_CC al_NN ._. [_NN 35_CD ]_NN found_VBD that_IN ATRIP_NNP
          Rad_NNP 26_CD and_CC ATR_NNP Rad_NNP 3_CD also_RB re-localize_JJ to_TO a_DT large_JJ number_NN of_IN
          intranuclear_NN foci_NN ._. DNA_NN repair_NN activities_NNS may_MD take_VB place_NN
          at_IN these_DT foci_NN since_IN BRCA_NNP 1_CD has_VBZ been_VBN shown_VBN to_TO co-localize_JJ
          with_IN ATR_NNP in_IN damage-induced_JJ foci_NN [_NN 58_CD ]_NN ._. Using_VBG elegant_JJ
          methods_NNS to_TO test_VB for_IN direct_JJ association_NN of_IN DNA_NNP damage_NN
          checkpoint_NN proteins_NNS at_IN double_JJ strand_NN breaks_NNS 
          in_IN vivo_NN ,_, other_JJ groups_NNS have_VBP shown_VBN
          that_IN MEC_NNP 1_CD Rad_NNP 3_CD -_: HA_NNP and_CC LCD_NNP 1_CD Rad_NNP 26_CD -_: GFP_NNP localize_NN to_TO sites_NNS of_IN
          DNA_NNP damage_NN [_NN 59_CD 60_CD ]_NN ._. However_RB ,_, MEC_NNP 1_CD was_VBD required_VBN for_IN
          this_DT re-localization_JJ of_IN LCD_NNP 1_CD -_: GFP_NNP 
          in_IN vivo_NN [_NN 60_CD ]_NN ._. Thus_RB ,_, while_IN
          re-localization_JJ of_IN Rad_NNP 26_CD /_NN Rad_NNP 3_CD -_: related_VBN complexes_NNS to_TO sites_NNS
          of_IN DNA_NNP repair_NN may_MD be_VB evolutionarily_RB conserved_JJ ,_, the_DT
          regulation_NN of_IN these_DT complexes_NNS is_VBZ not_RB ._.
          Unlike_IN ATRIP_NNP and_CC LCD_NNP 1_CD -_: GFP_NNP ,_, Rad_NNP 26_CD -_: GFP_NNP also_RB localizes_NNS to_TO
          one_CD or_CC two_CD bright_JJ spots_NNS following_VBG DNA_NNP damage_NN (_( Figure_NN 5_LS )_) ._.
          We_PRP speculate_VBP that_IN these_DT spots_NNS could_MD represent_VB "_'' control_NN
          centers_NNS "_'' where_WRB various_JJ kinds_NNS of_IN information_NN about_IN the_DT
          status_NN of_IN the_DT genome_NN is_VBZ integrated_VBN with_IN cell_NN cycle_NN
          progression_NN in_IN fission_NN yeast_NN ._. We_PRP tested_VBD if_IN these_DT spots_NNS
          were_VBD associated_VBN with_IN the_DT spindle_NN pole_NN body_NN (_( SPB_NNP )_) ,_, given_VBN
          that_IN an_DT ultimate_JJ receiver_NN of_IN the_DT checkpoint_NN signal_NN ,_, Cdc_NNP 2_CD ,_,
          resides_VBZ at_IN the_DT SPB_NNP prior_RB to_TO mitosis_NNS in_IN fission_NN yeast_NN [_NN 61_CD
          ]_NN ._. However_RB ,_, these_DT Rad_NNP 26_CD -_: GFP_NNP foci_NN did_VBD not_RB co-localize_JJ
          with_IN a_DT SPB_NNP marker_NN ,_, Sad_NNP 1_CD (_( data_NNS not_RB shown_VBN )_) [_NN 62_CD ]_NN ._.
        
      
      
        Conclusion_NNP
        We_PRP have_VBP discovered_VBN three_CD distinct_JJ Rad_NNP 26_CD -_: GFP_NNP cellular_JJ
        structures_NNS ._. Since_IN formation_NN of_IN these_DT structures_NNS did_VBD not_RB
        require_VB other_JJ checkpoint_NN proteins_NNS ,_, including_VBG Rad_NNP 3_CD ,_, we_PRP
        believe_VBP that_IN they_PRP represent_VBP very_RB early_JJ steps_NNS in_IN the_DT
        checkpoint_NN response_NN to_TO damaged_VBN DNA_NNP that_WDT may_MD be_VB controlled_VBN
        entirely_RB by_IN Rad_NNP 26_CD ._.
        In_IN normal_JJ cycling_NN cells_NNS ,_, Rad_NNP 26_CD -_: GFP_NNP localized_VBN to_TO a_DT small_JJ
        number_NN of_IN dots_NNS that_WDT may_MD function_VB as_IN surveillance_NN centers_NNS
        and_CC monitor_VB the_DT genome_NN for_IN DNA_NNP damage_NN ._. After_IN damage_NN ,_,
        Rad_NNP 26_CD -_: GFP_NNP localization_NN to_TO speckles_NNS may_MD correspond_VB to_TO the_DT
        direct_JJ interaction_NN of_IN Rad_NNP 26_CD with_IN sites_NNS of_IN damage_NN ._. At_IN the_DT
        bright_JJ spots_NNS ,_, Rad_NNP 26_CD may_MD integrate_VB various_JJ kinds_NNS of_IN
        information_NN about_IN the_DT status_NN of_IN the_DT genome_NN with_IN cell_NN cycle_NN
        regulators_NNS ._. Further_RB study_NN of_IN these_DT structures_NNS and_CC their_PRP$
        regulation_NN could_MD provide_VB important_JJ new_JJ information_NN about_IN
        the_DT early_JJ steps_NNS in_IN DNA_NNP damage_NN detection_NN and_CC the_DT checkpoint_NN
        pathway_NN ._.
      
      
        Methods_NNP
        
          Strains_NNP ,_, Growth_NNP Conditions_NNP and_CC Physiological_NNP
          Methods_NNP
          The_DT strains_NNS used_VBN in_IN this_DT study_NN (_( Table_NNP 1_LS )_) were_VBD grown_VBN at_IN
          30_CD °_NN C_NNP under_IN standard_JJ conditions_NNS [_NN 63_CD ]_NN unless_IN noted_VBD
          otherwise_RB ._. Bleomycin_NNP (_( Sigma_NNP ,_, St_NNP Louis_NNP ,_, MO_NNP )_) was_VBD prepared_VBN
          as_IN a_DT 3_CD U_NNP /_NN ml_NN stock_NN solution_NN in_IN water_NN and_CC kept_VBD at_IN -_: 20_CD °_NN C_NNP ._. To_TO
          activate_VBP the_DT DNA_NNP damage_NN checkpoint_NN ,_, Bleomycin_NNP was_VBD added_VBN
          to_TO cultures_NNS (_( optical_JJ density_NN of_IN 0_CD ._. 3_LS )_) at_IN a_DT concentration_NN
          of_IN 5_CD mU_NN /_NN ml_NN for_IN 3_CD hours_NNS [_NN 28_CD ]_NN ._. Thiabendazole_NNP (_( Sigma_NNP )_) was_VBD
          prepared_VBN in_IN DMSO_NNP as_IN described_VBN previously_RB [_NN 45_CD ]_NN and_CC added_VBD
          to_TO cooled_VBN ,_, YE_NNP 5_CD S_NNP agar_NN prior_RB to_TO pouring_VBG plates_NNS ._. We_PRP did_VBD not_RB
          observe_VB an_DT affect_NN of_IN DMSO_NNP on_IN the_DT growth_NN of_IN any_DT strains_NNS
          used_VBN in_IN this_DT study_NN (_( data_NNS not_RB shown_VBN )_) ._.
          To_TO arrest_VB the_DT 
          cdc_NN 25_CD ._. 22_CD rad_NN 26_CD -_: GFP_NNP strain_NN at_IN the_DT
          G_NNP 2_CD /_NN M_NNP boundary_NN ,_, TE_NNP 1198_CD was_VBD grown_VBN at_IN 30_CD °_NN C_NNP in_IN liquid_JJ ,_,
          complete_JJ media_NNS to_TO O_NNP ._. D_NNP ._. 0_CD ._. 3_CD ._. Next_JJ ,_, cells_NNS were_VBD collected_VBN by_IN
          centrifugation_NN and_CC re-inoculated_JJ to_TO the_DT same_JJ density_NN in_IN
          pre-warmed_JJ 37_CD °_NN C_NNP liquid_JJ media_NNS ._. They_PRP were_VBD grown_VBN for_IN 3_CD hours_NNS
          at_IN this_DT temperature_NN to_TO cause_VB cell_NN cycle_NN arrest_NN at_IN the_DT
          G_NNP 2_CD /_NN M_NNP boundary_NN before_IN fixation_NN ._.
        
        
          Microscopy_NNP
          To_TO observe_VB Rad_NNP 26_CD -_: GFP_NNP in_IN live_VB cells_NNS ,_, yeast_NN were_VBD grown_VBN
          in_IN YE_NNP 5_CD S_NNP liquid_JJ medium_NN to_TO an_DT optical_JJ density_NN of_IN 0_CD ._. 5_CD ,_,
          washed_VBD three_CD times_NNS in_IN phosphate_NN buffered_JJ saline_NN (_( pH_NN 7_CD ._. 4_LS )_)
          and_CC mounted_VBD on_IN poly-_NN L-_NNP lysine_NN (_( Sigma_NNP )_) coated_JJ coverslips_NNS
          http_NN :_: /_NN /_NN www_NN ._. bio_NN ._. uva_NN ._. nl_NN /_NN pombe_NN /_NN handbook_NN ._. A_DT 4_CD μl_NN volume_NN of_IN
          Slowfade_NNP Component_NNP A_DT (_( Molecular_NNP Probes_NNP ,_, Eugene_NNP ,_, OR_NNP )_) was_VBD
          placed_VBN on_IN the_DT coverslips_NNS ,_, which_WDT were_VBD finally_RB mounted_VBN on_IN
          glass_NN slides_NNS ._. A_DT Zeiss_NNP Axioskop_NNP 2_CD was_VBD used_VBN to_TO observe_VB
          specimens_NNS ,_, and_CC images_NNS were_VBD captured_VBN with_IN the_DT SenSys_NNP
          digital_JJ camera_NN (_( Photometrics_NNP ,_, Tucson_NNP ,_, Az_NNP )_) and_CC processed_VBN
          using_VBG IP_NNP Lab_NNP software_NN (_( Fairfax_NNP ,_, VA_NNP )_) ._.
          To_TO paraformaldehyde-fix_JJ cells_NNS ,_, ~_NN 30_CD %_NN paraformaldehyde_NN
          (_( Sigma_NNP )_) stock_NN solution_NN [_NN 64_CD ]_NN was_VBD added_VBN to_TO ~_NN 3_CD %_NN in_IN yeast_NN
          cultures_NNS for_IN ten_CD minutes_NNS before_IN cells_NNS were_VBD washed_VBN and_CC
          mounted_VBN on_IN coverslips_NNS ._. Alternatively_RB ,_, cells_NNS were_VBD
          extracted_VBN with_IN Triton_NNP X-_NNP 100_CD before_IN methanol_NN fixation_NN ,_, as_IN
          described_VBN previously_RB [_NN 42_CD ]_NN ._. To_TO visualize_VB nuclei_NN ,_, 1_CD
          μg_NN /_NN ml_NN 4_CD ,_, 6_CD -_: diamidino-_NN 2_CD -_: phenylindole_NN (_( DAPI_NNP )_) was_VBD added_VBN to_TO
          Slowfade_NNP Component_NNP A_DT ._.
          To_TO observe_VB the_DT microtubule_NN cytoskeletons_NNS of_IN 
          rad_NN 26_CD Δ_NN and_CC 
          rad_NN 3_CD Δ_NN ,_, cells_NNS were_VBD processed_VBN for_IN
          immunofluorescence_NN microscopy_NN using_VBG standard_JJ combined_VBN
          aldehyde_NN (_( formaldehyde_NN and_CC methanol_NN )_) fixation_NN and_CC TAT_NNP 1_CD
          monoclonal_NN antibodies_NNS [_NN 65_CD ]_NN ._.
        
        
          Construction_NNP of_IN rad_NN 26_CD -_: GFP_NNP Strains_NNP
          Two_CD long_JJ primers_NNS (_( 
          prad_NN 26_CD forward_RB :_:
          TATTTTCTCACTACAGAATTGTTGGAAGTTTGCGTCTCTCCCGAAGAGCTGGAGCAGTTGTACACTAATTTTCGGATCCCCGGGTTAATTAA_NNP ;_:
          
          prad_NN 26_CD reverse_VB :_:
          GATGTGGGTGCGGGACGGGAAAGAACAACACTGAAGAAACAAGTATCATTATTTCATTTGAAAAATTAGGGAAATGAATTCGAGCTCGTTTAAAC_NNP )_)
          were_VBD used_VBN to_TO amplify_VB the_DT GFP_NNP (_( S_NNP 65_CD T_NN )_) -_: kanMX_NN 6_CD module_NN of_IN
          pFA_NN 6_CD a-_NN GFP_NNP (_( S_NNP 65_CD T_NN )_) -_: kanMX_NN 6_CD [_NN 41_CD ]_NN in_IN ten_CD separate_JJ 50_CD μl_NN PCR_NNP
          reactions_NNS using_VBG Accuzyme_NNP ,_, high-fidelity_NN polymerase_NN
          (_( Bioline_NNP ,_, Randolph_NNP ,_, MA_NNP )_) ._. These_DT primers_NNS contain_VBP sequences_NNS
          that_WDT are_VBP homologous_RB to_TO those_DT that_DT flank_NN both_DT sides_NNS of_IN the_DT
          
          rad_NN 26_CD +_NN STOP_NNP codon_NN [_NN 13_CD ]_NN ._. By_IN
          homologous_RB integration_NN ,_, they_PRP direct_JJ integration_NN of_IN GFP_NNP
          (_( S_NNP 65_CD T_NN )_) to_TO the_DT 3_CD '_POS -_: end_NN of_IN 
          rad_NN 26_CD +_NN ._. The_DT PCR-product_NNP was_VBD
          pooled_VBN ,_, extracted_VBN with_IN phenol_NN :_: chloroform_NN :_: isoamyl_NN alcohol_NN
          (_( 25_CD :_: 24_CD :_: 1_LS )_) ,_, precipitated_VBD with_IN ethanol_NN and_CC dissolved_VBN in_IN
          water_NN ._. This_DT DNA_NNP was_VBD then_RB used_VBN to_TO transform_VB TE_NNP 696_CD (_( 
          rad_NN 26_CD +_NN )_) and_CC TE_NNP 1102_CD (_( 
          rad_NN 26_CD ._. T_NN 12_CD )_) to_TO Geneticin_NNP (_( Life_NNP
          Technologies_NNPS ,_, Rockville_NNP ,_, MD_NNP )_) -_: resistance_NN as_IN described_VBN by_IN
          Bahler_NNP 
          et_CC al_NN ._. [_NN 41_CD ]_NN ._. Integrants_NNP were_VBD
          verified_VBN by_IN Western_NNP blotting_VBG using_VBG anti-_NN Rad_NNP 26_CD polyclonal_NN
          antibodies_NNS [_NN 18_CD ]_NN to_TO show_VB that_IN the_DT genomic_JJ copy_NN of_IN 
          rad_NN 26_CD +_NN or_CC 
          rad_NN 26_CD ._. T_NN 12_CD had_VBD been_VBN replaced_VBN by_IN 
          rad_NN 26_CD -_: GFP_NNP or_CC 
          rad_NN 26_CD ._. T_NN 12_CD -_: GFP_NNP ,_, respectively_RB (_( data_NNS
          not_RB shown_VBN )_) ._. Rad_NNP 26_CD -_: GFP_NNP was_VBD followed_VBN through_IN crosses_VBZ using_VBG
          Geneticin-resistance_NNP and_CC Western_NNP blotting_VBG to_TO confirm_VB that_DT
          
          rad_NN 26_CD +_NN was_VBD completely_RB replaced_VBN with_IN
          
          rad_NN 26_CD -_: GFP_NNP (_( data_NNS not_RB shown_VBN )_) ._.
        
      
    
  
